Industry News
Pharmaceutical Industry News
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown
Eli Lilly’s Trulicity dethrones Dupixent, taking January's TV ad spending crown badams Fri, 02/04/2022 - 08:17
Fierce Pharma Asia—AstraZeneca China’s fraud investigation; Women promoted at Takeda; Samsung buy of Biogen’s stake in biosimilar JV
Fierce Pharma Asia—AstraZeneca China's fraud investigation; Women promoted at Takeda; Samsung buy of Biogen's stake in biosimilar JV kdunleavy Fri, 02/04/2022 - 06:34
Takeda taps a doctor turned patient—and spread-the-word artist—for rare disease awareness campaign
Takeda taps a doctor turned patient—and spread-the-word artist—for rare disease awareness campaign badams Fri, 02/04/2022 - 04:43
In Roche’s rosy pandemic scenario, it will take a $2B hit to COVID sales this year
In Roche's rosy pandemic scenario, it will take a $2B hit to COVID sales this year tstaton Thu, 02/03/2022 - 16:03
Roche, Novartis CEOs pull down $12M-plus each in 2021 pay
Roche, Novartis CEOs pull down $12M-plus each in 2021 pay esagonowsky Thu, 02/03/2022 - 15:41
Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
Connected TV works 'harder and smarter' for the ad dollar, new analysis finds nmissakian Thu, 02/03/2022 - 15:35
F.D.A. Nominee Faces Steep Climb to Senate Confirmation
Dr. Robert Califf, a former agency commissioner, is encountering opposition over federal opioid and abortion policies and his industry ties.
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too badams Thu, 02/03/2022 - 11:42
Roche revs up new launches—and a slew of data readouts—as it emerges from the biosim trough
Roche revs up new launches—and a slew of data readouts—as it emerges from the biosim trough tstaton Thu, 02/03/2022 - 11:39
Eli Lilly nixes Verzenio’s phase 3 HER2-positive early breast cancer trial
Eli Lilly nixes Verzenio's phase 3 HER2-positive early breast cancer trial fkansteiner Thu, 02/03/2022 - 11:26
Pfizer’s oral antiviral might be better, but Merck still expects $5B-plus from molnupiravir in 2022
Pfizer's oral antiviral might be better, but Merck still expects $5B-plus from molnupiravir in 2022 kdunleavy Thu, 02/03/2022 - 11:01
Takeda’s Sequeira to head up newly created global portfolio division, Kim to lead US unit
Takeda's Sequeira to head up newly created global portfolio division, Kim to lead US unit esagonowsky Thu, 02/03/2022 - 10:28
B. Braun gets FDA nod for new IV manufacturing site in Florida amid continued IV fluid shortages
B. Braun gets FDA nod for new IV manufacturing site in Florida amid continued IV fluid shortages jkeenan Thu, 02/03/2022 - 09:05
After disastrous start to launch, Biogen still expects ‘minimal’ sales from Aduhelm this year
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year esagonowsky Thu, 02/03/2022 - 08:47
Cancer screening ‘not elective,’ says president’s cancer panel, as it pushes for better awareness
Cancer screening 'not elective,' says president's cancer panel, as it pushes for better awareness badams Thu, 02/03/2022 - 06:14
AbbVie’s blockbuster eye drug Restasis under threat as FDA approves Viatris’ copycat
AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat esagonowsky Wed, 02/02/2022 - 15:56
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations kdunleavy Wed, 02/02/2022 - 11:52
DHL earmarks $400M to expand its pharma, medical device supply chain network this year
DHL earmarks $400M to expand its pharma, medical device supply chain network this year jkeenan Wed, 02/02/2022 - 10:44
Novartis says Leqvio launch will feature a ‘modest initial ramp,’ but blockbuster potential awaits
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits esagonowsky Wed, 02/02/2022 - 10:22
Novo touts diabetes, obesity growth, but Wegovy supply woes remain top of mind
Novo touts diabetes, obesity growth, but Wegovy supply woes remain top of mind fkansteiner Wed, 02/02/2022 - 09:17